Aprea Therapeutics, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | -$0.62 | -$0.62 | -$0.62 |
Q2 2024 | 2 | -$0.83 | -$0.59 | -$0.72 |
Q3 2024 | 0 | -$0.73 | -$0.73 | -$0.73 |
Q1 2025 | 1 | -$0.80 | -$0.80 | -$0.80 |
Q2 2025 | 1 | -$0.41 | -$0.41 | -$0.41 |
Q3 2025 | 1 | -$0.44 | -$0.44 | -$0.44 |
Q4 2025 | 1 | -$0.47 | -$0.47 | -$0.47 |
Aprea Therapeutics, Inc. Earnings Date And Information
Aprea Therapeutics, Inc. last posted its earnings results on Monday, August 12th, 2024. The company reported $-0.58 earnings per share for the quarter, topping analysts' consensus estimates of $-0.64 by $0.06. The company had revenue of 561,574 for the quarter and had revenue of 583,231 for the year. Aprea Therapeutics, Inc. has generated $-4 earnings per share over the last year ($-3.95 diluted earnings per share) and currently has a price-to-earnings ratio of -1.26. Aprea Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based on prior year's report dates.
Aprea Therapeutics, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
08/12/2024 | Q2 2024 | -$0.64 | -$0.58 | 0.06 | $50,000 | $561,574 |
05/14/2024 | Q1 2024 | -$0.78 | -$0.67 | 0.11 | $380,569 | |
03/26/2024 | Q4 2023 | -$0.56 | -$0.92 | -0.36 | $14,075 | |
11/09/2023 | Q3 2023 | -$1.08 | -$0.86 | 0.22 | $125,000 | $319,468 |
08/10/2023 | Q2 2023 | -$1.43 | -$0.87 | 0.56 | $249,688 | |
05/15/2023 | Q1 2023 | -$1.51 | -$1.27 | 0.24 | $0 | |
03/30/2023 | Q4 2022 | -$834.43 | $0 | |||
11/09/2022 | Q3 2022 | -$5.60 | -$2.41 | 3.19 | $0 | |
08/12/2022 | Q2 2022 | -$86.76 | $0 | |||
05/16/2022 | Q1 2022 | -$7.60 | -$7.25 | 0.35 | $0 | |
03/15/2022 | Q4 2021 | -$8.80 | -$7.20 | 1.6 | $0 | |
11/08/2021 | Q3 2021 | -$8.80 | -$8.90 | -0.1 | $0 | |
08/12/2021 | Q2 2021 | -$9.40 | -$9.68 | -0.28 | $0 | |
05/06/2021 | Q1 2021 | -$10.40 | -$9.13 | 1.27 | $0 | |
03/16/2021 | Q4 2020 | -$12.60 | -$14.53 | -1.93 | $0 | |
11/06/2020 | Q3 2020 | -$11.63 | $0 | |||
08/11/2020 | Q2 2020 | -$12.00 | -$15.51 | -3.51 | $0 | |
05/15/2020 | Q1 2020 | -$11.40 | -$8.93 | 2.47 | $0 | |
03/27/2020 | Q4 2019 | -$12.87 | $0 | |||
11/14/2019 | Q3 2019 | -$78.87 | -$6.29 | 72.58 | $0 |
Aprea Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Aprea Therapeutics, Inc.'s earnings date?
Aprea Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based off last year's report dates.
-
Did Aprea Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Aprea Therapeutics, Inc. (:APRE) reported $-0.58 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.64 by $0.06.
-
How can I listen to Aprea Therapeutics, Inc.'s earnings conference call?
The conference call for Aprea Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Aprea Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Aprea Therapeutics, Inc.'s latest earnings report can be read online.
-
How much revenue does Aprea Therapeutics, Inc. generate each year?
Aprea Therapeutics, Inc. (:APRE) has a recorded annual revenue of $583,231.
-
How much profit does Aprea Therapeutics, Inc. generate each year?
Aprea Therapeutics, Inc. (:APRE) has a recorded net income of $583,231. Aprea Therapeutics, Inc. has generated $-3.95 earnings per share over the last four quarters.
-
What is Aprea Therapeutics, Inc.'s price-to-earnings ratio?
Aprea Therapeutics, Inc. (:APRE) has a price-to-earnings ratio of -1.26 and price/earnings-to-growth ratio is -0.01.